Brief: U.S. Defense Dpartment To Study Pluristem's PLX-R18 For Treatment Of Mustard Gas Injuries

Pluri

19/06/2018 12:13

June 19 (Reuters) - Pluristem Therapeutics Inc  PSTI.O :
    * U.S. DEPARTMENT OF DEFENSE TO STUDY PLURISTEM’S PLX-R18
FOR THE
TREATMENT OF MUSTARD GAS INJURIES
    * PLURISTEM THERAPEUTICS INC - STUDIES ON COMPANY'S PLX-R18
CELL
THERAPY PRODUCT TO BE FUNDED BY U.S. NATIONAL INSTITUTES OF
HEALTH
    * PLURISTEM THERAPEUTICS-DOD STUDYING PLX-R18 EFFECTIVENESS
AS
NOVEL MEDICAL COUNTERMEASURE FOR ACUTE RADIATION SYNDROME BEFORE
HIGH RADIATION EXPOSURE

Source text for Eikon:  ID:nGNX3jV77D 
Further company coverage:  PSTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))